The US drug regulator has completed a pre-approval inspection at Emcure’s Ahmedabad oncology facility without issuing a Form ...

Capricor Therapeutics is expected to release data from the phase 3 HOPE-3 trial in Q3'25, thus presenting a potential path ...

Emcure Pharma share price rose in trade after the company announced that United States Food and Drug Administration (USFDA) ...

From Fleetworthy's Drivewyze, the new capability in select ELDs automatically transfers fleet and vehicle registration ...

For a pharmaceutical company, a clean FDA inspection report is crucial for maintaining and expanding its presence in global markets ...

The feature follows pilot programs and is now available to fleets passing through weigh station sites in Nevada. Initial ...

00:21 Drivewyze by Fleetworthy has launched a new feature that securely and automatically transfers fleet and vehicle ...

Pune: Emcure Pharma has announced that the United States Food and Drug Administration (USFDA) has concluded a Pre-Approval ...

The Kenya Bureau of Standards (Kebs) wants a case challenging a lucrative tender for inspection of goods before leaving the ...

Capricor Therapeutics (CAPR) announced the completion of the Food and Drug Administration’s pre-license inspection of its San Diego manufacturing facility for Deramiocel, the company’s lead ...

Kebs invited tenders in January for Pre-Export Verification Conformity (PVOC), for the years 2025-2028. A total of 19 firms ...